Efficacy and safety of Olmesartan medoxomil in elderly patients with mild to moderate hypertension. Randomised, double blind, active-control study in two parallel groups of patients with mild to moderate hypertension

Trial Profile

Efficacy and safety of Olmesartan medoxomil in elderly patients with mild to moderate hypertension. Randomised, double blind, active-control study in two parallel groups of patients with mild to moderate hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Olmesartan medoxomil; Ramipril
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Menarini
  • Most Recent Events

    • 01 Apr 2011 Results published in Blood Pressure.
    • 21 Jun 2010 Results presented at the 20th European Meeting on Hypertension
    • 21 Jun 2010 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top